In the global pharmaceutical industry, there were 479 M&A deals announced in Q2 2023, worth a total value of $51bn, according to GlobalData’s Deals Database. The $10.8bn acquisition of prometheus biosciences by merck was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity decreased by 30% in Q2 2023 compared with the previous quarter’s total of $72.5bn and rose by 77% as compared to Q2 2022. Related deal volume increased by 18% in Q2 2023 versus the previous quarter and was 151% higher than in Q2 2022.
Notably, healthcare-related deals accounted for a 26% share of the global pharmaceutical industry’s M&A activity in Q2 2023, up 6% over the previous quarter.
The top-ranked financial advisors supporting these M&A deals in Q2 2023 were Centerview Partners; Stifel Financial; Bank of America with 14, 8, 7 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q2 2023 were Kirkland & Ellis; Cooley; Gibson, Dunn & Crutcher with 17, 14, 13 deals respectively.
For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
